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An overview of National Typhoid and Paratyphoid Fever Surveillance (NTPFS) system is available online 
http://www.cdc.gov/ncezid/dfwed/PDFs/typhi_surveillance_overview_508c.pdf. 
 
National Typhoid and Paratyphoid Fever Surveillance Data  
 
States reporting at least one typhoid or paratyphoid fever1 case to the NTPFS during 2009 are shown in 
Figures 1 and 2.  
 44 states and the District of Columbia reported 431 typhoid fever cases (Figure 1) 
 24 states reported 115 paratyphoid fever cases (115 Paratyphi A) (Figure 2) 
 
Figure 1. States reporting at least typhoid fever case to National Typhoid and Paratyphoid Fever 
Surveillance, 2010 (n=431) 
 
                                                     
1
 Paratyphoid fever is caused by Salmonella serotypes Paratyphi A, Paratyphi B, and Paratyphi C. Two distinct 
pathotypes of Paratyphi B are recognized; one is associated with paratyphoid fever and the other is associated 
with uncomplicated gastroenteritis. The two pathotypes have distinct virulence characteristics, and are 
differentiated based on the ability to ferment tartrate. The paratyphoidal pathotype is unable to ferment tartrate 
and is designated serotype Paratyphi B; the nonparatyphoidal pathotype ferments tartrate and is designated 
serotype Paratyphi B var. L(+) tartrate+. Only those laboratory-confirmed as not able to ferment tartrate are 
included in the annual NTPFS summary.  For many Paratyphi B reports submitted to CDC, this information is not 
available; these reports are therefore excluded from the NTPFS summary. 
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Figure 2. States reporting at least one paratyphoid fever case to National Typhoid and Paratyphoid Fever 
Surveillance, 2010 (N=115, 115 Paratyphi A) 
 
 
 
Demographic and clinical characteristics of patients with typhoid fever and paratyphoid fever are shown 
in Tables 1 and 2. 
 The median age of patients with typhoid fever was 23 years 
 The median age of patients with paratyphoid fever was 27 years  
 One patient with typhoid fever died (0.3%) 
 
Table 1. Demographic and clinical characteristics of patients with typhoid fever reported to National 
Typhoid and Paratyphoid Fever Surveillance, 2010 (n=431). 
 
Characteristic (total number) Count Percent 
Median age in years (range) 23 (<1-77) -- 
Female (n=431) 273  50 
US Citizen (n=397) 199  50 
Vaccinated* (n=420) 13  3 
Site of isolation (n=420)   
Blood  364  87 
Stool  49  12 
Gall bladder  7  2 
Other  0  0 
Hospitalized (n=431) 312  72 
Died (n=404) 1 0.3 
*Received typhoid vaccination within 5 years before onset 
of illness 
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Table 2. Demographic and clinical characteristics of patients with paratyphoid fever reported to National 
Typhoid and Paratyphoid Fever Surveillance, 2010 (n=115). 
 
Characteristic (total number) Count  Percent 
Median age in years (range) 27 (1-68) -- 
Female (n=115) 60  52 
US Citizen (n=109) 54  50 
Vaccinated* (n=111) 14  13 
Site of isolation (n=113)   
Blood  92  81 
Stool  19  17 
Gall bladder  1  1 
Other  0  0 
Hospitalized (n=115) 67  58 
Died (n=113) 0  0 
*Received typhoid vaccination within 5 years before onset 
of illness 
 
 
Travel destinations are shown in Table 3. 
 361 (84%) patients with typhoid fever and 103 (89%) patients with paratyphoid fever reported 
traveling or living outside the United States in the 30 days before illness onset 
 Visiting friends or relatives was the most common reason for travel for patients with typhoid 
fever (59%) and paratyphoid fever (64%) 
 
Table 3. Travel destinations reported to National Typhoid and Paratyphoid Fever Surveillance, 2010 
(n=331). 
 
Travel Destination  Typhoid (n=361) Paratyphoid (n=103) 
 no. (%) no. (%) 
India 210 (58) 60 (58) 
Bangladesh 57 (16) 19 (18) 
Pakistan 23 (6) 10 (10) 
Haiti 12 (3) -- 
Mexico 12 (3) -- 
Other 47 (13) 14 (14) 
 
 
 
NNDSS Data 
 
The National Notifiable Disease Surveillance System (NNDSS) collects and compiles reports of nationally 
notifiable infectious diseases, including typhoid fever. Reports can be found at 
http://www.cdc.gov/mmwr/mmwr_nd/index.html  
 
 
Antimicrobial Resistance Data 
 
The National Antimicrobial Resistance Monitoring System (NARMS) monitors antimicrobial resistance 
among enteric bacteria (including Salmonella serotype Typhi and Paratyphi A, Paratyphi B, and Paratyphi 
C) from humans.  In Enterobacteriaceae, resistance to nalidixic acid, an elementary quinolone, correlates 
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with decreased susceptibility to ciprofloxacin (MIC ≥0.12 μg/mL) and possible fluoroquinolone 
treatment failure. Multidrug resistance is described in NARMS as resistance to three or more classes of 
antimicrobial agents, as defined by the Clinical and Laboratory Standards Institute (CLSI). 
 
The most recently published NARMS annual report is from 2010, available at 
http://www.cdc.gov/narms/pdf/2010-annual-report-narms.pdf (2).  The 2010 data showed the 
following:    
 
For Salmonella serotype Typhi isolates 
 69% were resistant to nalidixic acid 
 3% were resistant to ciprofloxacin 
 14% were multidrug  resistant 
 
For Salmonella serotype Paratyphi isolates 
 90% were resistance to nalidixic acid 
 0% were resistant to ciprofloxacin 
 2% were multidrug  resistant  
 
 
Outbreak Data 
 
The Foodborne Disease Outbreak Surveillance System (FDOSS) collects reports of foodborne disease 
outbreaks from local, state, tribal, and territorial public health agencies.  Reports can be found at 
http://cdc.gov/outbreaknet/surveillance_data.html.  
 
 In 2010, one typhoid fever outbreak was reported with 12 cases in three states. Consumption of 
frozen mamey pulp in a fruit shake was reported by 75% of patients. Traceback investigations 
implicated 2 brands of frozen mamey pulp from a single manufacturer in Guatemala, which was 
also implicated in the last domestically acquired typhoid fever outbreak, a 1998-1999 outbreak 
of typhoid fever in Florida. 
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